Assembly Biosciences
ASMB
106 hedge funds and large institutions have $286M invested in Assembly Biosciences in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 42 increasing their positions, 20 reducing their positions, and 24 closing their positions.
45,071% more call options, than puts
Call options by funds: $7.68M | Put options by funds: $17K
110% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 20
21% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 24
3% more funds holding
Funds holding: 103 → 106 (+3)
0.33% less ownership
Funds ownership: 7.21% → 6.88% (-0.33%)
34% less capital invested
Capital invested by funds: $435M → $286M (-$149M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$13.8M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$10.4M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$4.32M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.63M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$18.3M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$17.7M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$11.1M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$9.54M |
| 5 |
O
OrbiMed
New York
|
-$7.48M |
ASMB Hedge Fund Activity: Q2 2019 in Review
106 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2019, worth a combined $286M — down 34% from $435M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ASMB positions and 24 closed out — a net gain of 5 holders — while 42 added to existing stakes and 20 trimmed.
The largest buyer was Armistice Capital, adding an estimated $13.8M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $18.3M sold.
- 106 institutional investors held Assembly Biosciences (ASMB) as of Q2 2019, up from 103 in Q1 2019.
- Funds reported $286M of Assembly Biosciences stock for Q2 2019, down 34% quarter-over-quarter.
- 29 funds opened new Assembly Biosciences positions in Q2 2019 and 24 closed out, a net change of +5 holders.
- The largest Assembly Biosciences buyer in Q2 2019 was Armistice Capital, an estimated $13.8M added.
- The largest Assembly Biosciences seller in Q2 2019 was EcoR1 Capital, an estimated $18.3M sold.
Based on aggregated 13F filings for Q2 2019.